Wikipedia
Rigosertib
Rigosertib (ON-01910 sodium salt, with Estybon as trade name) is a synthetic benzyl styryl sulfone that is in phase III clinical trials as an anti-cancer agent.
Its geometrical isomer (Z)-ON 01910·Na has less cytotoxicity on cancer cells.